International Biotechnology Trust Plc (IBT.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 08/31
(Values in thousands)
| 08-2025 | 08-2024 | 08-2023 | 08-2022 | 08-2021 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | 9 | 14 | -25 | -33 | -781 |
| Other Working Capital | 1,775 | -732 | 22,063 | 228 | -42,418 |
| Other Operating Activity | 26,849 | 46,070 | 5,261 | 929 | 28,666 |
| Operating Cash Flow | $28,633 | $45,352 | $27,299 | $1,124 | $-14,533 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 31,106 | 46,186 | N/A | N/A | N/A |
| Debt Repayment | -23,345 | -21,456 | N/A | N/A | N/A |
| Common Stock Issued | N/A | N/A | N/A | 0 | 23,557 |
| Common Stock Repurchased | -20,490 | -16,160 | -9,978 | -3,534 | N/A |
| Dividend Paid | -11,196 | -10,768 | -11,407 | -12,879 | -11,564 |
| Financing Cash Flow | $-23,925 | $-2,198 | $-21,385 | $-16,413 | $11,993 |
| Exchange Rate Effect | -161 | -247 | 1,588 | -4,375 | N/A |
| Beginning Cash Position | 10,433 | -32,474 | -39,976 | -20,312 | -17,772 |
| End Cash Position | 14,980 | 10,433 | -32,474 | -39,976 | -20,312 |
| Net Cash Flow | $4,708 | $43,154 | $5,914 | $-15,289 | $-2,540 |
| Free Cash Flow | |||||
| Operating Cash Flow | 28,633 | 45,352 | 27,299 | 1,124 | -14,533 |
| Free Cash Flow | 28,633 | 45,352 | 27,299 | 1,124 | -14,533 |